Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group

Patients with soft tissue sarcoma (STS), even after complete local disease control, often relapse locally or with distant metastases. This multicenter phase II study was conducted to evaluate the safety and efficacy of the combination of pegylated liposomal doxorubicin (PLD) and paclitaxel, as first...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bafaloukos, D, Papadimitriou, C, Linardou, H, Aravantinos, G, Papakostas, P, Skarlos, D, Kosmidis, P, Fountzilas, G, Gogas, H, Kalofonos, C, Dimopoulos, A M
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2004
Sujets:
Clinical
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409958/
https://ncbi.nlm.nih.gov/pubmed/15494721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602148
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires